Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

scientific article published on 09 July 2019

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1473-3099(19)30300-7
P698PubMed publication ID31300331

P50authorFrançois RomanQ104745044
Marc LievensQ106991877
P2093author name stringAnangisye Malabeja
John Lusingu
Samwel Gesase
Erik Jongert
Halidou Tinto
Innocent Valéa
Lode Schuerman
Lucas Otieno
Hermann Sorgho
Edwin Liheluka
Walter Otieno
Daniel Valia
Yolanda Guerra Mendoza
Anne Wangwe
Emilia Gvozdenovic
Valentine Sing'oei
P2860cites workA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsQ28278852
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysisQ33529052
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trialQ34043843
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in AfricaQ35428630
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African ChildrenQ37130595
From the circumsporozoite protein to the RTS, S/AS candidate vaccineQ37608882
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparumQ42126049
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countriesQ43032696
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African childrenQ46182948
Cerebral malariaQ57244021
P433issue8
P921main subjectmalariaQ12156
phase III clinical trialQ42824827
P304page(s)821-832
P577publication date2019-07-09
P1433published inLancet Infectious DiseasesQ15724248
P1476titleLong-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial
P478volume19

Reverse relations

cites work (P2860)
Q89644089Balancing in a black box: Potential immunomodulatory roles for TGF-β signaling during blood-stage malaria
Q94602401Malaria vaccines: facing unknowns
Q89514056Plasmodium falciparum pre-erythrocytic stage vaccine development
Q90639766The Delay in the Licensing of Protozoal Vaccines: A Comparative History

Search more.